Recent Transactions

Zhong Lun Advises on Structure Therapeutics’ IPO on Nasdaq 2023-02-06

On February 3, 2023, Structure Therapeutics Inc. (Nasdaq: GPCR) announced its initial public offering and listing of American depositary shares on the Nasdaq Global Market. The total offering size will be approximately US$161.1 million prior to the exercise of the over-allotment option. Jefferies, SVB Securities, Guggenheim Securities and BMO Capital Markets acted as the joint bookrunners for this offering.  


Structure Therapeutics is a clinical-stage global biopharmaceutical company aiming to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its initial focus is on G-protein-coupled receptors as a therapeutic target class.


Zhong Lun Law Firm acted as the PRC legal advisor to the issuer in this offering. The legal team from Zhong Lun was led by Anthony Zhao and William Jia, and included Roy Zheng, Ruby Zheng, etc. Jerry Fang also provided support in his area of expertise.